📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Biological Dynamics

1.1 - Company Overview

Biological Dynamics Logo

Biological Dynamics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of next-gen liquid biopsy solutions using a true multiomics approach to detect early cancer in blood; offers the ExoVerita Pro system and platform for automated exosome isolation via alternating current electrokinetics; develops exosome- and proteomics-based diagnostic assays; leads ExoLuminate pancreatic cancer study; and runs a Technology Access Program offering partners access to Biological Dynamics' system for diagnostic solutions.

Products and services

  • ExoVerita Pro Platform: Research-grade technology that enables rapid, easy isolation of exosomes to advance oncology research and facilitate early disease detection workflows from blood for next-generation liquid biopsy applications
  • Verita Technology Applications: Multiomics-based initiative that develops diagnostic assays for early cancer detection in blood by leveraging exosomes and proteomics for oncology research
  • ExoVerita Pro System: Laboratory-grade, automated bench-top device that isolates exosomes from biofluids using alternating current electrokinetics, simplifying and standardizing workflows for research

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Biological Dynamics

Elucigene Logo

Elucigene

HQ: United Kingdom Website
  • Description: Provider of clinical diagnostic assays and product realisation services, offering kits for cystic fibrosis (CFTR mutations), rapid aneuploidy analysis (QF-PCR for trisomies 21, 18, 13 and sex chromosome aneuploidies), reproductive health (recurrent miscarriage, male infertility, Y-microdeletion), and genetic disease diagnosis (thrombophilia, alpha-1-antitrypsin). Services include assay development, validation, manufacturing, regulatory strategy, and commercial sale and distribution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elucigene company profile →
Alios Biopharma Logo

Alios Biopharma

HQ: United States Website
  • Description: Provider of novel medicines for viral diseases, leveraging platform technologies including small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate-protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alios Biopharma company profile →
TcLand Expression Logo

TcLand Expression

HQ: France Website
  • Description: Provider of companion diagnostics development in Immune Mediated Disorders and biomarker development in Solid Organ Transplantation, supported by strong immunology expertise and preferred access to patient cohorts, searching and developing biomarkers for a wide range of grafts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TcLand Expression company profile →
Personal Genome Diagnostics Logo

Personal Genome Diagnostics

HQ: United States Website
  • Description: Provider of patient-specific cancer genome analysis tools and comprehensive genomic profiling kits, including PGDx elio tissue complete (FDA cleared, CE-IVD marked) for in-house tumor profiling of over 500 genes identifying somatic mutations (SNVs, indels, TMB, MSI, select amplifications/translocations); PGDx elio plasma complete liquid biopsy for research across over 500 genes (SNVs, indels, bTMB, MSI, LOH); and PGDx elio plasma focus targeting 33 cancer genes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Personal Genome Diagnostics company profile →
Arbor Biosciences Logo

Arbor Biosciences

HQ: United States Website
  • Description: Provider of genomics and synthetic biology products and services, including myTXTL cell-free protein expression kits, myBaits hybridization capture probes, targeted next-generation sequencing kits, cytogenetics in situ hybridization probes, and DNA/RNA sequencing and bioinformatics services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arbor Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Biological Dynamics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Biological Dynamics

2.2 - Growth funds investing in similar companies to Biological Dynamics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Biological Dynamics

4.2 - Public trading comparable groups for Biological Dynamics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Biological Dynamics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Biological Dynamics

What does Biological Dynamics do?

Biological Dynamics is a provider of next-gen liquid biopsy solutions using a true multiomics approach to detect early cancer in blood; offers the ExoVerita Pro system and platform for automated exosome isolation via alternating current electrokinetics; develops exosome- and proteomics-based diagnostic assays; leads ExoLuminate pancreatic cancer study; and runs a Technology Access Program offering partners access to Biological Dynamics' system for diagnostic solutions.

Who are Biological Dynamics's competitors?

Biological Dynamics's competitors and similar companies include Elucigene, Alios Biopharma, TcLand Expression, Personal Genome Diagnostics, and Arbor Biosciences.

Where is Biological Dynamics headquartered?

Biological Dynamics is headquartered in United States.

How many employees does Biological Dynamics have?

Biological Dynamics has 1,000 employees 🔒.

When was Biological Dynamics founded?

Biological Dynamics was founded in 2010 🔒.

What sector and industry vertical is Biological Dynamics in?

Biological Dynamics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Biological Dynamics

Who are the top strategic acquirers in Biological Dynamics's sector and industry

Top strategic M&A buyers and acquirers in Biological Dynamics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Biological Dynamics?

Top strategic M&A buyers groups and sectors for Biological Dynamics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Biological Dynamics's sector and industry vertical

Which are the top PE firms investing in Biological Dynamics's sector and industry vertical?

Top PE firms investing in Biological Dynamics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Biological Dynamics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Biological Dynamics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Biological Dynamics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Biological Dynamics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Biological Dynamics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Biological Dynamics?

The key public trading comparables and valuation benchmarks for Biological Dynamics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Biological Dynamics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Biological Dynamics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Biological Dynamics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Biological Dynamics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Biological Dynamics's' sector and industry vertical?

Access recent funding rounds and capital raises in Biological Dynamics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Biological Dynamics